ORMP

#3277
Oramed Pharmaceuticals Inc. - Common Stock
3.9 7 USD
+0.25%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
3.97
3.97
년간 변동
1.98
5.01
일일 변동
+0.25%
월간 변동
+2.85%
6달 변화
+41.79%
년간 변동율
+74.89%
이전 종가
3.9 6
Open
3.9 7
저가
3.9 7
High
3.9 7
양
8
전체 차트 열기 Full chart

Financials

개요 성명 통계 배당금
4분기 연간
  • Market Capitalization 162.48 M
  • Employee 13
  • Founded 2006
  • CEO Nadav Kidron
  • Website www.oramed.com
  • Headquarter Delaware, United States
  • FIGI BBG000LRYR36
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
1.9
주가매출액비율
60.45
주당 배당금
0.25
배당수익률 %
8.77

Oramed Pharmaceuticals Inc. - Common Stock

Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.

뉴스